Skip to main content
. 2024 Apr 21;12:tkad063. doi: 10.1093/burnst/tkad063

Figure 1.

Figure 1

Geographical distribution of OX, BB, BBOX or None therapy use. Left: relative likelihood; right: absolute number of patients per region. OX oxandrolone only, BB beta blocker only, BBOX concomitant BB and OX, None none of these drugs (BB, OX and BBOX)